跳至主要内容
临床试验/IRCT201011112696N2
IRCT201011112696N2已完成2 期

Effects of Diabetan and Saliva officinalis L tablets on blood glucose levels of patients with type 2 DM.

Gol Daru Co.0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 149 years(—)
性别
All

入选标准

  • Inclusion Criteria: 1-Having type 2 diabetes based on internal criteria with FBS=126 or more and blood glucose 200 or more in daytime. 2- HbA1C more than 7% and less than 9% 3-Not having side effects of DM 4-Non- insulin dependent 5-Willing to participate in the trial 6-Not having a crucial illness 7- psychologically normal 8- Not using any other drugs for other diseases. Excluding Criteria: 1- Hyperglycemia with HbA1C more than 250 2-2hpp more than 9% and less than 7% 3-Pragnancy and lactation 4- Using insulin 5- Not willing to enter the trial 6- Having side effects of DM 7- Cardiovascular, hepatic, renal and other major systemic diseases 8- psychologically abnormal 9- Using drugs for other illnesses 10- Type 1 DM 11- Age less than 30 years

排除标准

  • 未提供

研究者

发起方
Gol Daru Co.

相似试验